Related Articles
Methylation of STK11 promoter is a risk factor for tumor stage and survival in clear cell renal cell carcinoma
Engrailed‑2 promoter hyper‑methylation is associated with its downregulation in clear cell renal cell carcinoma
Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma
Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma
p16, MGMT, RARβ2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions